Frazier Lifesciences Acquisition Corp

Frazier Lifesciences Acquisition Corp, trading under the ticker FLAC, is a blank-check company that filed its S-1 registration statement with the SEC on November 20, 2020, targeting the life sciences and healthcare sector. The SPAC was sponsored by Frazier Lifesciences, an affiliate of the established healthcare-focused investment firm Frazier Healthcare Partners, bringing deep sector expertise and an existing network of life sciences relationships to the vehicle. FLAC pursued acquisition targets within biotechnology, medical devices, diagnostics, and related healthcare sub-industries. For complete filing history, deal timeline, sponsor background, and real-time status updates on FLAC, sign up for full data access at SpacDesk.